Citigroup’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.93M | Buy |
+10,000
| New | +$3.29M | ﹤0.01% | 2398 |
|
|
2025
Q2 | – | Sell |
-13,500
| Closed | -$5.87M | – | 5714 |
|
|
2025
Q1 | $5.87M | Buy |
13,500
+10,600
| +366% | +$4.26M | ﹤0.01% | 1763 |
|
|
2024
Q4 | $1.07M | Hold |
2,900
| – | – | ﹤0.01% | 3309 |
|
|
2024
Q3 | $1.51M | Hold |
2,900
| – | – | ﹤0.01% | 2919 |
|
|
2024
Q2 | $1.57M | Hold |
2,900
| – | – | ﹤0.01% | 2549 |
|
|
2024
Q1 | $1.5M | Buy |
2,900
+2,500
| +625% | +$1.24M | ﹤0.01% | 2681 |
|
|
2023
Q4 | $189K | Sell |
400
-3,000
| -88% | -$1.39M | ﹤0.01% | 3940 |
|
|
2023
Q3 | $1.48M | Hold |
3,400
| – | – | ﹤0.01% | 2215 |
|
|
2023
Q2 | $1.51M | Hold |
3,400
| – | – | ﹤0.01% | 2488 |
|
|
2023
Q1 | $1.56M | Sell |
3,400
-18,200
| -84% | -$8.66M | ﹤0.01% | 2191 |
|
|
2022
Q4 | $11.1M | Buy |
21,600
+15,600
| +260% | +$7.92M | 0.01% | 1076 |
|
|
2022
Q3 | $2.73M | Sell |
6,000
-20,000
| -77% | -$9.57M | ﹤0.01% | 1924 |
|
|
2022
Q2 | $12.5M | Buy |
26,000
+6,000
| +30% | +$2.97M | 0.01% | 1041 |
|
|
2022
Q1 | $9.82M | Buy |
+20,000
| New | +$9.14M | 0.01% | 1309 |
|
|
2021
Q2 | – | Sell |
-35,000
| Closed | -$12.6M | – | 6186 |
|
|
2021
Q1 | $12.6M | Buy |
35,000
+600
| +2% | +$193K | 0.01% | 1231 |
|
|
2020
Q4 | $11M | Sell |
34,400
-181,000
| -84% | -$55.5M | 0.01% | 1475 |
|
|
2020
Q3 | $57.9M | Sell |
215,400
-30,700
| -12% | -$8.26M | 0.04% | 388 |
|
|
2020
Q2 | $64.7M | Buy |
246,100
+147,200
| +149% | +$39.3M | 0.05% | 325 |
|
|
2020
Q1 | $22.5M | Sell |
98,900
-117,900
| -54% | -$32.1M | 0.02% | 673 |
|
|
2019
Q4 | $65.5M | Buy |
216,800
+82,000
| +61% | +$22.6M | 0.05% | 389 |
|
|
2019
Q3 | $32.4M | Buy |
134,800
+33,300
| +33% | +$9.12M | 0.03% | 650 |
|
|
2019
Q2 | $28.6M | Buy |
101,500
+23,200
| +30% | +$6.34M | 0.02% | 723 |
|
|
2019
Q1 | $22.5M | Sell |
78,300
-16,700
| -18% | -$4.83M | 0.02% | 763 |
|
|
2018
Q4 | $24.9M | Buy |
95,000
+55,100
| +138% | +$15.2M | 0.03% | 692 |
|
|
2018
Q3 | $10.9M | Sell |
39,900
-400
| -1% | -$104K | 0.01% | 1223 |
|
|
2018
Q2 | $9.59M | Sell |
40,300
-37,500
| -48% | -$8.68M | 0.01% | 1306 |
|
|
2018
Q1 | $17.1M | Buy |
77,800
+9,500
| +14% | +$2.23M | 0.01% | 877 |
|
|
2017
Q4 | $15.4M | Buy |
68,300
+14,700
| +27% | +$3.13M | 0.01% | 1006 |
|
|
2017
Q3 | $10.2M | Buy |
53,600
+10,000
| +23% | +$1.9M | 0.01% | 1224 |
|
|
2017
Q2 | $8.2M | Buy |
43,600
+18,100
| +71% | +$3.25M | 0.01% | 1294 |
|
|
2017
Q1 | $4.22M | Sell |
25,500
-11,300
| -31% | -$1.8M | ﹤0.01% | 1795 |
|
|
2016
Q4 | $5.29M | Sell |
36,800
-19,200
| -34% | -$2.57M | ﹤0.01% | 1779 |
|
|
2016
Q3 | $7.02M | Buy |
56,000
+27,700
| +98% | +$3.58M | 0.01% | 1356 |
|
|
2016
Q2 | $3.72M | Buy |
28,300
+9,200
| +48% | +$1.26M | ﹤0.01% | 1842 |
|
|
2016
Q1 | $2.65M | Sell |
19,100
-46,000
| -71% | -$6.15M | ﹤0.01% | 2183 |
|
|
2015
Q4 | $9.08M | Buy |
65,100
+28,700
| +79% | +$3.95M | 0.01% | 1226 |
|
|
2015
Q3 | $5.1M | Sell |
36,400
-200
| -0.5% | -$30.1K | ﹤0.01% | 1645 |
|
|
2015
Q2 | $6.01M | Sell |
36,600
-40,600
| -53% | -$6.49M | 0.01% | 1584 |
|
|
2015
Q1 | $11.9M | Buy |
77,200
+8,100
| +12% | +$1.15M | 0.01% | 1060 |
|
|
2014
Q4 | $8.68M | Buy |
69,100
+6,000
| +10% | +$741K | 0.01% | 1384 |
|
|
2014
Q3 | $7.55M | Sell |
63,100
-43,700
| -41% | -$5.01M | 0.01% | 1514 |
|
|
2014
Q2 | $11.5M | Buy |
106,800
+300
| +0.3% | +$30.9K | 0.01% | 1167 |
|
|
2014
Q1 | $10.6M | Sell |
106,500
-41,300
| -28% | -$3.74M | 0.01% | 1109 |
|
|
2013
Q4 | $13.7M | Buy |
147,800
+8,900
| +6% | +$791K | 0.01% | 1002 |
|
|
2013
Q3 | $11.6M | Sell |
138,900
-16,500
| -11% | -$1.41M | 0.01% | 1054 |
|
|
2013
Q2 | $12.7M | Buy |
+155,400
| New | +$11.6M | 0.01% | 924 |
|
Other funds holding ELV
VCM
VPM
Citigroup's ELV Position: Q1 2026 in Review
Citigroup increased its Elevance Health (ELV) stake by 10% in Q1 2026, buying an estimated $7.27M and bringing the position to 238,850 shares worth $69.9M. The position accounts for 0.03% of the portfolio, ranked #523.
Citigroup first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $174M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Citigroup held 238,850 shares of Elevance Health worth $69.9M as of Q1 2026.
- Citigroup bought 22,122 Elevance Health shares in Q1 2026, an estimated $7.27M.
- Elevance Health made up 0.03% of Citigroup's portfolio in Q1 2026, its #523 holding.
- Citigroup first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Citigroup's Elevance Health position peaked at $174M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.